Topics

Charles River completes acquisition of non-clinical CRO Citoxlab

07:58 EDT 30 Apr 2019 | Compelo Medical Devices

The deal is also said to be valued at around $500m based on current exchange rates and subject to customary closing adjustments. Citoxlab is a major CRO that

The post Charles River completes acquisition of non-clinical CRO Citoxlab appeared first on Compelo Medical Devices - Latest industry news and analysis.

Original Article: Charles River completes acquisition of non-clinical CRO Citoxlab

NEXT ARTICLE

More From BioPortfolio on "Charles River completes acquisition of non-clinical CRO Citoxlab"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...